{"version":"1.0","type":"link","title":"Real-World Utilization of Palbociclib as First-Line Treatment for Canadian HR+/HER2- Women with Metastatic Breast Cancer: Results from PALCAN Study.","author_name":"Rayson D 외","author_url":"https://prs-insight.online/author/Rayson%20D","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/88045","thumbnail_width":1200,"thumbnail_height":630}